Skip to content

T Lymphoblastic Leukemia Lymphoma C1301359

Published: July 22, 2026Updated: August 20, 2026

A fast-growing cancer of immature T-cell lymphocytes that can appear as leukemia in blood or lymphoma in lymph nodes. It most commonly affects children and young adults. Treatment typically involves intensive chemotherapy, with survival rates improving over time.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

Easy bruising

(hematologic)

Fever

(general)

Bone pain

(musculoskeletal)

Hypercalcemia

(endocrine)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Minimally invasive procedural intervention

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
2

Multi-Agent Induction Chemotherapy

Intensive multi-drug chemotherapy regimen combining corticosteroids, vincristine, asparaginase, and anthracyclines to achieve initial disease remission in lymphoblasts.

medication
3

Consolidation and Maintenance Chemotherapy

Prolonged chemotherapy phases including CNS-directed therapy, intrathecal methotrexate, and mercaptopurine-based regimens to prevent relapse and maintain remission.

procedure

Additional treatment options

Allogeneic Stem Cell Transplantation

Hematopoietic stem cell transplant from matched related or unrelated donor for high-risk patients or those with poor response to initial chemotherapy.

surgical

Minimal Residual Disease Monitoring

Sensitive molecular and flow cytometry techniques to detect residual leukemia cells during and after treatment, guiding therapeutic intensity adjustments.

monitoring

Psychosocial Support and Survivorship Care

Comprehensive support including counseling, educational support, fertility preservation counseling, and long-term follow-up for treatment-related late effects.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is T Lymphoblastic Leukemia Lymphoma C1301359?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. WHO Press. 2022.

guideline2022
2

Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review. Blood Cancer J. 2021.

review2021
3

Pui CH, Yang JJ, Hunger SP, et al. Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol. 2018.

clinical_trial2018
4

Lancaster HL, Jitschin R, Mikala G, et al. Immunotherapy approaches for T-cell acute lymphoblastic leukemia. Cancer Treat Rev. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat T Lymphoblastic Leukemia Lymphoma C1301359. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy